Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of CM512 in Patients With Chronic Rhinosinusitis With Nasal Polyposis (NEZHA-3)
Sponsor: Beijing Keymed Biosciences Co., Ltd.
Summary
This is a multi-center, randomized, double blind, placebo-controlled Phase III study to evaluate the efficacy and safety of CM512, and to observe the life quality of subjects, the Pharmacokinetics, Pharmacodynamics and immunogenicity of CM512 in patients with chronic rhinosinusitis with nasal polyposis (CRSwNP)
Official title: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase III Clinical Study to Evaluate the Efficacy and Safety of CM512 in Patients With Chronic Rhinosinusitis With Nasal Polyps
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
240
Start Date
2026-10
Completion Date
2028-07
Last Updated
2026-09-08
Healthy Volunteers
No
Interventions
CM512
subcutaneous injection
Placebo
subcutaneous injection
Locations (1)
Beijing Tongren Hospital, CMU
Beijing, Beijing Municipality, China